About Membio
Membio is a company based in Kitchener (Canada) founded in 2018 by Shane Kilpatrick and Megan Logan. Membio has raised $280 thousand across 3 funding rounds from investors including IndieBio, Accelerator Centre and Velocity. Membio operates in a competitive market with competitors including Limula, PBS Biotech, m2p-labs, CIMON Medical and Beijing Zhizhen Biotechnology, among others.
- Headquarter Kitchener, Canada
- Founders Shane Kilpatrick, Megan Logan
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$280 K (USD)
in 3 rounds
-
Latest Funding Round
$250 K (USD), Seed
Nov 01, 2019
-
Investors
IndieBio
& 2 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Membio
Membio has successfully raised a total of $280K across 3 strategic funding rounds. The most recent funding activity was a Seed round of $250 thousand completed in November 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Membio
Membio has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include IndieBio, Accelerator Centre and Velocity.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Biotech startups are accelerated through IndieBio's focused programs.
|
Locked | Locked | Locked | |
|
Startups are built and accelerated in a structured studio environment.
|
Locked | Locked | Locked | |
|
Velocity is supported as a startup incubator by the University of Waterloo.
|
Locked | Locked | Locked |
Investor details for Membio
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Membio
Investment portfolio details for Membio
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Membio
Detailed financials for Membio
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Membio Comparisons
Peer comparison for Membio
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Membio
Membio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Limula, PBS Biotech, m2p-labs, CIMON Medical and Beijing Zhizhen Biotechnology, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Modular solutions for on-demand cell therapy manufacturing are provided.
|
|
| Locked | Locked | Locked |
Developer of single-use bioreactors for the production of vaccines, therapeutic proteins, and cell therapies
|
|
| Locked | Locked | Locked |
Micro-bioreactors are provided for screening and bioprocess development.
|
|
| Locked | Locked | Locked |
Developer of a patented device for monitoring blood flow for early diagnosis
|
|
| Locked | Locked | Locked |
Provider of hematology testing instruments, reagents, and services
|
Detailed competitors of Membio
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Membio
Complete news archive for Membio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Membio
Membio was founded in 2018.
Membio is headquartered in Kitchener, Canada. It is registered at Kitchener, Ontario, Canada.
Shane Kilpatrick is the current CEO of Membio. They have also founded this company.
Membio is a funded company, having raised a total of $280K across 3 funding rounds to date.
Membio was founded in 2018 and is based in Kitchener, Canada. Operations focus on the biotechnology sector, where single-use bioreactors are developed for applications in cell and gene therapies. A benchtop bioreactor system is provided, featuring a proprietary design that maintains a consistent cellular environment across scales. This approach supports scalable processes in therapeutic development.
Membio's top competitors include PBS Biotech, m2p-labs and Limula.
Membio has 3 investors. Key investors include IndieBio, Accelerator Centre, and Velocity.